Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on August 11, 2026.

1.30% of the capital sold short

1 disclosing funds

437 disclosures on record

SE0009414576 ISIN code

Evolution of the disclosed total

0%1%2%3%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

The whole history, peaking at 8.43% on August 19, 2021. The shaded band is the year shown above.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
Fund	Twelve months	% of capital	Over the year	Since
GSA Capital Partners LLP		1.30%	new	August 11, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

History of disclosures

437 disclosures on record for this share.
Date	Fund	% of capital	End of publication
October 13, 2021	Citadel Advisors LLC	0.57%	still open
October 12, 2021	Worldquant LLC	0.92%	still open
October 12, 2021	Citadel Advisors LLC	0.00%	still open
October 11, 2021	Qube Research & Technologies Limited	0.89%	still open
October 11, 2021	Worldquant LLC	0.80%	still open
October 11, 2021	Mangrove Partners	0.73%	still open
October 11, 2021	Citadel Advisors LLC	0.51%	still open
October 8, 2021	Mangrove Partners	0.93%	still open
October 8, 2021	Worldquant LLC	0.67%	still open
October 8, 2021	Citadel Advisors LLC	0.00%	still open
October 7, 2021	Qube Research & Technologies Limited	1.02%	still open
October 7, 2021	Citadel Advisors LLC	0.70%	still open
October 7, 2021	Marshall Wace LLP	0.00%	still open
October 1, 2021	Arrowstreet Capital Limited Partnership	1.21%	still open
September 30, 2021	Citadel Advisors LLC	0.00%	still open
September 29, 2021	PDT Partners LLC	0.90%	still open
September 28, 2021	Marshall Wace LLP	0.79%	still open
September 20, 2021	Qube Research & Technologies Limited	0.67%	still open
September 17, 2021	Mangrove Partners	1.10%	still open
September 17, 2021	Qube Research & Technologies Limited	0.70%	still open
September 17, 2021	Citadel Advisors LLC	0.59%	still open
September 16, 2021	Qube Research & Technologies Limited	0.80%	still open
September 16, 2021	Citadel Advisors LLC	0.67%	still open
September 15, 2021	Qube Research & Technologies Limited	0.77%	still open
September 14, 2021	Citadel Advisors LLC	0.74%	still open
September 13, 2021	Mangrove Partners	1.00%	still open
September 13, 2021	Qube Research & Technologies Limited	0.64%	still open
September 10, 2021	Citadel Advisors LLC	0.82%	still open
September 8, 2021	Arrowstreet Capital Limited Partnership	1.19%	still open
September 8, 2021	Mangrove Partners	0.96%	still open
September 7, 2021	Citadel Advisors LLC	0.76%	still open
September 7, 2021	Consonance Capital Management LP	0.00%	still open
September 2, 2021	Marshall Wace LLP	0.86%	still open
September 2, 2021	Citadel Advisors LLC	0.81%	still open
September 2, 2021	Qube Research & Technologies Limited	0.53%	still open
August 31, 2021	Qube Research & Technologies Limited	0.00%	still open
August 30, 2021	Qube Research & Technologies Limited	0.54%	still open
August 27, 2021	Qube Research & Technologies Limited	0.00%	still open
August 26, 2021	Qube Research & Technologies Limited	0.55%	still open
August 24, 2021	Citadel Advisors LLC	1.06%	still open
August 24, 2021	Qube Research & Technologies Limited	0.73%	still open
August 23, 2021	Citadel Advisors LLC	1.12%	still open
August 20, 2021	Citadel Advisors LLC	1.35%	still open
August 20, 2021	Capital Fund Management SA	0.70%	still open
August 20, 2021	Qube Research & Technologies Limited	0.61%	still open
August 20, 2021	Consonance Capital Management LP	0.50%	still open
August 20, 2021	Worldquant LLC	0.00%	still open
August 19, 2021	Citadel Advisors LLC	1.22%	still open
August 19, 2021	Consonance Capital Management LP	0.84%	still open
August 19, 2021	Worldquant LLC	0.57%	still open

Other companies sold short in Sweden

Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
Elekta AB (publ) 9.63% of the capital sold short
JM AB 7.01% of the capital sold short
Hemnet Group AB (publ) 6.08% of the capital sold short
Embracer Group AB 5.75% of the capital sold short
Bonesupport Holding AB 5.58% of the capital sold short
Truecaller AB 5.43% of the capital sold short
Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
Tobii AB 4.34% of the capital sold short
RaySearch Laboratories AB (publ) 4.16% of the capital sold short
Dynavox Group AB 3.80% of the capital sold short
Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/oncopeptides-ab?page=6